
    
      Rwanda Has also completed a third study to assess the safety and efficacy of MC when
      performed by nurses using PrePex in both rural and urban hospitals, Device safety was
      assessed by the rate of clinical adverse events and device-related incidents attributed to
      the PrePex device and its procedures, the study report was shared with the WHO Male
      Circumcision Technical Advisory Group. On February 2011 the WHO provided Rwanda with
      recommendation to phase in MC scale up with the PrePex device on adults. Moreover the WHO
      recommended Rwanda to study the PrePex for use on adolescent population, starting on ages
      15-17 and thereafter on ages 12-14 and 10-12.
    
  